Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Federal Trade Commission
Dow
Merck
Chubb
Express Scripts
Daiichi Sankyo
Boehringer Ingelheim

Generated: August 18, 2018

DrugPatentWatch Database Preview

TERAZOL 3 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Terazol 3 patents expire, and when can generic versions of Terazol 3 launch?

Terazol 3 is a drug marketed by Janssen Pharms and is included in two NDAs.

The generic ingredient in TERAZOL 3 is terconazole. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the terconazole profile page.

Drug patent expirations by year for TERAZOL 3
Pharmacology for TERAZOL 3
Ingredient-typeAzoles
Drug ClassAzole Antifungal
Synonyms for TERAZOL 3
(2R,4S)-terconazole
1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine
1-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-(propan-2-yl)piperazine
1-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine
1-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)-4-(propan-2-yl)piperazine
1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
1-[4-[[(2R)-2alpha-(2,4-Dichlorophenyl)-2beta-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4beta-yl]methoxy]phenyl]-4-(1-methylethyl)piperazine
67915-31-5
915T315
AB00513849
AB00513849_07
AC1L9B2M
AK135621
AKOS016846147
AS-14153
AX8152619
BDBM50375318
BIDD:GT0705
BPBio1_000429
BRD-K86204871-001-02-2
BSPBio_000389
C08080
C26H31Cl2N5O3
CAS-67915-31-5
CCG-213216
CHEBI:82980
CHEMBL1306
cis-1-(p-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-isopropylpiperazine
CS-6456
CT0256
D00888
DB00251
DSSTox_CID_25498
DSSTox_GSID_45498
DSSTox_RID_80917
DTXSID2045498
EINECS 267-751-6
Fungistat
Gyno-Terazol
HE071220
HE378988
HMS2096D11
HMS2233C22
HY-B1790
J-008500
KB-217439
KM1155
KS-00000H43
KS-1463
LS-176634
MFCD05662369
MLS002153844
MolPort-006-133-612
NCGC00016912-01
NCGC00179575-01
NSC 331942
NSC-760361
NSC760361
Panlomyc
Pharmakon1600-01503847
Piperazine, 1-(4-(((2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)-, rel-
Piperazine, 1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)-, cis-
Prestwick3_000495
R 42,470
R 42470
R-42470
SCHEMBL23165
SMR001233206
SR-01000841196
SR-01000841196-2
Terazol
Terazol 3 (TN)
Terazol 7
Terazol 7 & 3
Terazol Cream & Suppositories
Terconazol
Terconazol [INN-Spanish]
terconazole
Terconazole (USAN/INN)
Terconazole [USAN:INN:BAN]
Terconazolum
Terconazolum [INN-Latin]
Tercospor
Tox21_110679
Triaconazole
UNII-0KJ2VE664U component BLSQLHNBWJLIBQ-OZXSUGGESA-N
Zazole
ZINC3873936

US Patents and Regulatory Information for TERAZOL 3

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms TERAZOL 3 terconazole CREAM;VAGINAL 019964-001 Feb 21, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms TERAZOL 3 terconazole SUPPOSITORY;VAGINAL 019641-001 May 24, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for TERAZOL 3

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms TERAZOL 3 terconazole CREAM;VAGINAL 019964-001 Feb 21, 1991 ➤ Sign Up ➤ Sign Up
Janssen Pharms TERAZOL 3 terconazole SUPPOSITORY;VAGINAL 019641-001 May 24, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Harvard Business School
Federal Trade Commission
Fuji
Medtronic
UBS
Johnson and Johnson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.